MedPath

BIO CONCEPTS PTY. LTD.

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

127

TGA:127

Drug Approvals

FemmeBiotic Clinical (490766)

Product Name
FemmeBiotic Clinical
Approval Date
Jun 4, 2025
TGA

Cognisense Pro (490646)

Product Name
Cognisense Pro
Approval Date
Jun 3, 2025
TGA

Quercedran Ultrasorb (489707)

Product Name
Quercedran Ultrasorb
Approval Date
May 23, 2025
TGA

Gut Mx (488729)

Product Name
Gut Mx
Approval Date
May 14, 2025
TGA

Quercedran Plus (487212)

Product Name
Quercedran Plus
Approval Date
Apr 30, 2025
TGA

LM II (484385)

Product Name
LM II
Approval Date
Mar 27, 2025
TGA

Orthoplex Zinc Citrate (484388)

Product Name
Orthoplex Zinc Citrate
Approval Date
Mar 27, 2025
TGA

RestoraSleep (482530)

Product Name
RestoraSleep
Approval Date
Mar 14, 2025
TGA

AdrenoSupport (482528)

Product Name
AdrenoSupport
Approval Date
Mar 14, 2025
TGA

Phospholipid Complex (478128)

Product Name
Phospholipid Complex
Approval Date
Feb 7, 2025
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.